$PGNX 5.42 This dip is an over-reaction to phase 2 data for their prostrate cancer offering data, IMHO and represents a good buying time pre AdCom March 10-11 Relistor
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.